To know more about Retinitis Pigmentosa, please click here.

(c) GenSight Biologics

GenSight receives approval for PIONEER trial to evaluate GS030, a combination Gene Therapy & Device treatment for patients with RP. May test AMD later.

GenSight Biologics, a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced UK Medicines and Healthcare Regulatory Agency (MHRA) acceptance of the Company’s Clinical Trial Application (CTA) to initiate the PIONEER Phase I/II study of GS030 in patients with Retinitis Pigmentosa (RP).

Surgery in monkey eye

Stem-cell derived retina found to improve vision in monkeys with RP

Researchers at the RIKEN Institute in Japan have succeeded in growing human embryonic stem cell-derived retina (hESC-retina) and transplanting that tissue into the retinas of rhesus monkeys with Retinitis Pigmentosa (RP). Three weeks after the treatment, visual tests on two of the monkeys found their vision had improved. In the study, published in the journal PNAS,

READ MORE…

blue-light-neuron

RetroSense Therapeutics Gets Approval for Clinical Trials in Retinitis Pigmentosa

RetroSense Therapeutics’ Investigational New Drug (IND) application for gene therapy based clinical trial for their product RST-001 has received clearance from the US Food and Drug Administration. RetroSense is developing RST-001 for the treatment of retinitis pigmentosa, a genetic condition that leads to the progressive degeneration of rod and cone photoreceptors (cells found in the retina that sense light),

READ MORE…

Ball of progenitor cells injected into the eye

UCI-led team begins first clinical trial of stem cell-based retinitis pigmentosa treatment

Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa. The product of stem cell research at UCI’s Gavin Herbert Eye Institute and Sue & Bill Gross Stem Cell Research Center, these retinal progenitors are similar to stem cells in terms of potential regenerative

READ MORE…

Visit to Belize

This project has been made possible by a grant from Allergan Foundation. Driving to BCVI’s National Eye Clinic BCVI’s National Eye Clinic BCVI’s National Eye Clinic Belize City Pouring rain in Belize City An ROP baby being examined in the clinic Discussing the outcomes of the exam with the mother Discussing the outcomes of the

READ MORE…

Rosemary may have a beneficial effect for patients with Age-related macular degeneration and Retinitis Pigmentosa

Scientists at the Del E Web Center for Neuroscience, Aging, and Stem Cell Research, Sanford-Burnham Medical Research Institute, La Jolla, California, have found that carnosic acid (CA), present in rosemary extract, may potentially have clinical application to diseases affecting the outer retina, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). Read more…